Target intelligence / Profile preview

MSRA divergent transcript (MSRA-DT)

Target
MSRA-DT
Molecular classification
Long non-coding RNA (lncRNA), Divergent transcript, Promoter-associated transcript, Antisense RNA
01

Overview

MSRA divergent transcript (MSRA-DT) refers to a long non-coding RNA molecule produced by bidirectional transcription at the promoter region of the *MSRA* gene. Divergent transcripts are a widespread genomic phenomenon in mammals, typically arising from active promoters and often associated with regulatory genes[1][3][5]. These RNAs are antisense to the coding gene, may participate in chromatin modulation, and can influence transcriptional regulation and sometimes post-transcriptional events such as mRNA stability[1][3][5]. However, as a class rather than a well-characterized unique molecule, "MSRA divergent transcript" does not meet criteria for a canonical therapeutic target, lacks an independently defined gene symbol, and is not recognized as a direct subject of drug targeting or disease biomarker utility. If more context or a specific transcript ID is provided, more detailed functional annotation may be possible.

Other names
Promoter upstream transcript from MSRAMSRA antisense transcriptMSRA LUAT (long upstream antisense transcript)MSRA PROMPT (promoter upstream transcript)
02

Biological functions

Regulation of transcription (general role for divergent lncRNAs)Modulation of chromatin structurePotential influence on mRNA stability or translation (context-dependent)
03

Disease associations

Other (no direct evidence for “MSRA divergent transcript” itself in disease)Possible indirect roles if regulating MSRA gene (MSRA is involved in redox regulation and may be linked to cell protection in oxidative stress, but this transcript itself has no proven disease association)

Beyond the preview

Go deeper on MSRA divergent transcript (MSRA-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MSRA divergent transcript (MSRA-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call